Highest-materiality recent filing
Oxbridge Re posts Q2 net income of $176K; launches AI GridWorks for data center development
Q2 2026 net income of $176K ($0.02/share) vs net loss of $1.87M ($0.25/share) in Q2 2025; no underwriting losses recorded.
Oxbridge Re Q4 net income $120K, full-year loss narrows; token returns beat targets
Q4 2025 net income $120K ($0.02/share) vs net loss $460K ($0.05 loss/share) year ago.
Oxbridge Re borrows $1M at 16% rate, secures with all assets via 6-month note
$1M principal borrowed from Real World Digital Assets LLC; 6-month maturity through Aug 14, 2026.
Oxbridge Re subsidiary launches $20M tokenized participation share offering
SurancePlus Inc. offering up to 2,000,000 Participation Shares at $10 each via digital tokens T20-2027 and T42-2027.
Authorized shares increased from 50M to 500M (450M new shares) via amendment to Memorandum and Articles, effective immediately.
Oxbridge Re Q2 net loss $1.87M; loss ratio 394% from Hurricane Milton
Net loss for Q2 2025: $1.87M ($0.25 per share) vs $821K ($0.14) in Q2 2024; six-month loss $2.01M ($0.28).
Oxbridge Re reports FY 2024 net loss of $2.7M, improved from $9.9M; premiums up 83%
Net loss $2.7M ($0.45/share) vs $9.9M ($1.69) prior year; Q4 net loss $460K vs $2.67M prior year.
Oxbridge Re raises $3.0M via registered direct offering and warrants issuance
Sold 705,884 ordinary shares, 529,413 Series A warrants, and 882,355 Series B warrants at $4.25 combined effective price.
Oxbridge Re Q3 net loss narrows to $540K from $7.3M; new token offerings planned
Net loss of $540K ($0.09/share) vs $7.3M ($1.24) in Q3 2023; nine-month loss $2.27M vs $7.2M.
Oxbridge Re Q2 net loss $821K; completes $2.88M tokenized reinsurance placement
Net loss $821K ($0.14 per share) for Q2 2024 vs net loss $85K ($0.01) in Q2 2023; year-to-date net loss $1.73M vs net profit $57K prior year.
Oxbridge Re evaluates strategic alternatives including sale or merger
Board formed Special Committee to explore strategic alternatives for Co. and/or Web-3 unit SurancePlus Holdings.
Oxbridge Re Q1 net loss $905K vs net income $142K; premiums earned $549K
Net loss of $905K (($0.15) per share) vs net income $142K ($0.02) in Q1 2023.
Oxbridge Re FY2023 net loss widens to $9.9M; tokenized reinsurance returns >45%
Net loss of $9.9M ($1.69/share) for FY2023 vs $1.8M ($0.31/share) loss in prior year.
SurancePlus, Oxbridge Re subsidiary, commenced offering of up to 1,000,000 Participation Shares at $10 per share, represented by digital tokens 'EpsilonCat Re'.
Oxbridge Re Q3 net loss $7.3M vs $2.2M YoY; SurancePlus generates $300K in fees
Net loss of $7.3M ($1.24 diluted EPS) in Q3 2023 vs $2.2M ($0.37) YoY; nine-month loss $7.2M ($1.23) vs $2.5M.
Oxbridge Re Q2 net loss $85k; SurancePlus token offering raises $2.45M; SPAC merger closed
Q2 2023 net loss of $85,000 ($0.01 per share) vs net income of $77,000 ($0.01 per share) in Q2 2022.
Oxbridge Re posts Q1 net income of $142k; launches SurancePlus token offering
Q1 2023 net income $142k ($0.02 per share) vs net loss $387k ($0.07 loss) in Q1 2022.
Q4 net income $678k ($0.12 EPS) vs $1.6M ($0.27) prior year; full year net loss $1.8M ($0.31) vs income $8.6M ($1.49).
Oxbridge Re Q3 net loss $2.2M vs income $6.5M; Hurricane Ian drives underwriting loss
Net loss of $2.2M ($0.37/share) in Q3 2022, compared to net income of $6.5M ($1.14/share) in Q3 2021.
Oxbridge Re enters ATM equity facility for up to $6.3M; estimates Hurricane Ian loss up to $500k
Enters Equity Distribution Agreement with Maxim Group LLC to sell up to $6.3M of ordinary shares at-the-market, with a 3% commission.
Oxbridge Re swings to FY2021 profit of $8.6M on $9.2M SPAC unrealized gain
FY2021 net income $8.6M ($1.49 diluted EPS) vs net loss $50K (-$0.01) in FY2020.
accepted the resignation of Mr. Raymond Cabillot as an independent director of the Company, effective immediately.
appointed Mr. Arun Gowda to serve as an independent director on the Board of the Company, effective immediately.
On November 11, 2022, the Board of Oxbridge Re Holdings Limited appointed Mr. Dwight Merren, to serve as an independent director on the Board of the Company, effective immediately, and Oxbridge Reinsurance Limited (“OxRe”), subject to approval of the Cayman Islands Monetary Authority (“CIMA”).
On November 11, 2022, the Board of Directors (the “Board”) of Oxbridge Re Holdings Limited (the “Company”) accepted the resignation of Mr. Kris Persaud as an independent director of the Company, effective immediately.
On November 12, 2021, the Board also expanded the size of the Board to five members and appointed Wrendon Timothy, effective immediately, to serve as a director on the boards of Oxbridge Re Holdings Limited and Oxbridge Reinsurance Limited.
On November 12, 2021, the Board of Directors (the “Board”) of Oxbridge Re Holdings Limited (the “Company”) appointed Ms. Lesley Thompson, effective immediately, to serve as a director on the boards of the Company and Oxbridge Reinsurance Limited (“OxRe”).
On June 30, 2021, Dr. Mayur Patel, a director of Oxbridge Re Holdings Limited (the “Company”), notified the Company that he has decided to resign from the Company’s Board of Directors effective June 30, 2021.
Max materiality 0.75 · Median 0.55 · Most common event other_material